Phase 1 safety, tolerability, and pharmacokinetic study of single ascending doses of XM17 (recombinant human follicle-stimulating hormone) in downregulated healthy women

BACKGROUND: XM17 is a recombinant human follicle-stimulating hormone (follitropin alfa) for stimulation of multifollicular development in women undergoing controlled ovarian hyper-stimulation during assisted reproductive therapy and for treatment of anovulation. Manufactured using Chinese hamster ov...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int J Womens Health
Päätekijät: Lammerich, Andreas, Bias, Peter, Gertz, Beate
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove Medical Press 2015
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4509534/
https://ncbi.nlm.nih.gov/pubmed/26213478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJWH.S83418
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia